• Kontakt
• So finden Sie uns
• Klinikumseinrichtungen
• Presse

Most important recent publications

Lange B, Vavra, Kern WV, Wagner D. Development of tuberculosis in immunocompromised patients with positive tuberculosis-specific interferon-gamma release assay. International Journal of Tuberculosis and Lung Disease 2011 (in press).

van Ingen J, Wagner D. Epidemiology of nontuberculous mycobacterial disease in Germany and worldwide. Der Pneumologe 2011; 8(6):396-403. doi: 10.1007/s10405-011-0483-9. Der Pneumologe.

Thoden J, Rieg S, Venhoff N, Wennekes V, Schmitt-Graeff A, Wagner D, Kern WV. Fatal hemophagocytic syndrome in a patient with a previously well-controlled asymptomatic HIV infection after EBV reactivation. J Infect. 2012;64(1):110-2. PubMed.

Held J, Wagner D. β-D-Glucan kinetics for the assessment of treatment response in P. jirovecii pneumonia. Clin Microbiol Infec 2011, 17(7):1118-22.Pubmed.

Wagner D, Kern WV. [Tuberculosis and nontuberculous mycobacterial infections]. Dtsch Med Wochenschr. 2011 Apr;136(14):691-4. Pubmed.

Diel R, Goletti D, Ferrara G, Bothamley G, Cirillo D, Kampmann B, Lange C, Losi M, Markova R, Migliori GB, Nienhaus A, Ruhwald M, Wagner D, Zellweger JP, Huitric E, Sandgren A, Manissero D. Interferon-g release assays for the diagnosis of latent M. tuberculosis infection: A systematic review and meta-analysis. Eur Respir J. 2011 Jan;37(1):88-99. ERJ .

Sotgiu G, Centis R, D'ambrosio L, De Lorenzo S, D'arcy Richardson M, Lange C, Manissero D, Migliori GB; TBNET MDR-TB project (Collaborators: Kliiman K, Guenther G, Muetterlein R, Sester M, Wagner D, Cirillo D, Goletti D, Villar M, Spanu V, Zellweger JP, Bothamley G, Kampmann B.). Development of a standardised tool to survey MDR-/XDR-TB case management in Europe. Eur Respir J. 2010 Jul;36(1):208-11.Pubmed .

Lange B, Vavra M, Kern WV, Wagner D. Indeterminate Results of a TB-specific INFγ Release Assay in Immunocompromised Patients. Europ Resp Journal 2010 35: 1179-1182. ERJ.

Jha S, Danelishvili L, Wagner D, Maser J, Li Y, Moric I, Vogt S, Yamazaki Y, Lai B, Bermudez L. Virulence-related Mycobacterium avium MAV_2928 gene is associated with vacuole remodeling in macrophages. BMC Microbiol. 2010 Apr 1;10(1):100. BMC Micro.

Rieg S, Meier B, Fähnrich E, Huth A,Wagner D, Kern WV, Kalbacher H. Differential activity of innate defense antimicrobial peptides against Nocardia species. BMC Microbiol 2010, 10:61. Pubmed.

Rieg S, Bauer TM, Peyerl-Hoffmann G, Held J, Ritter W, Wagner D, Kern WK, Serr A. Paenibacillus larvae bacteremia in injection drug users. Emerg Inf Dis. 2010 Pubmed.

Li Y, Danelishvili L, Wagner D, Petrofsky M, Bermudez LE. Identification of virulence determinants of Mycobacterium avium which impact the ability to resist host killing mechanisms. J Med Microbiol 2010, 52: 59-16 Pubmed.

Rieg S, Peyerl-Hoffmann G, de With K, Theilacker C, Wagner D, Hübner J, Dettenkofer M, Kaasch A, Seifert H, Schneider C, Kern WV. Mortality of S. aureusbacteremia and infectious diseases specialist consultation - A study of 521 patients in Germany. J Infect. 2009, 59: 232-9. Pubmed.

Rodrigues L, Wagner D, Viveiros M, Sampaio D, Couto I, Vavra M, Kern WV, Amaral L. Thioridazine and chlorpromazine inhibition of ethidium bromide efflux in Mycobacterium avium and Mycobacterium smegmatis. J Antimicrob Chemother. 2008 May;61(5):1076-82. Pubmed.

Wagner D, Horster R, Lange B, Lange C. [Evaluation of T-cell interferon-gamma-release assays for the diagnosis of latent and active tuberculosis]. Dtsch Med Wochenschr 2008; 133(8):354-357. Pubmed.

Linder K, Zia M, Kern WV, Pfau RK, Wagner D. Relapses vs. reactions in multibacillary leprosy: proposal of new relapse criteria. Trop Med Int Health 2008; 13(3):295-309. Pubmed.

Lange C, Grobusch MP, Wagner D. [Extensively drug-resistant tuberculosis]. Dtsch Med Wochenschr 2008; 133(8):374-376. Pubmed.

Eker B, Ortmann J, Migliori GB et al. Multidrug- and extensively drug-resistant tuberculosis, Germany. Emerg Infect Dis 2008; 14(11):1700-1706. Pubmed.

Wagner D, Vos M, Buiting AG, Serr A, Bergmans AM, Kern W, Schouls LM. "Mycobacterium tilburgii" infections. Emerg Infect Dis 2006; 12(3): 532-534. Pubmed.

Wagner D, Maser J, Moric I, Vogt S, Kern WV, Bermudez LE. Elemental analysis of the Mycobacterium avium phagosome in Balb/c mouse macrophages. Biochem Biophys Res Commun 2006; 344(4): 1346-1351. Pubmed.

Schwacha H, Kern WV, Wagner D. Perforation of a Dacron vascular endoprosthesis into the duodenum. Endoscopy 2006; 38 Suppl 2:E51. Pubmed.

Wagner D, Sangari FJ, Parker A, Bermudez LE. fecB, a gene potentially involved in iron transport in Mycobacterium avium, is not induced within macrophages. FEMS Microbiol Lett 2005; 247(2):185-191.

Wagner D, Sander A, Bertz H, Finke J, Kern WV. Breakthrough invasive infection due to Debaryomyces hansenii (teleomorph Candida famata) and Scopulariopsis brevicaulis in a stem cell transplant patient receiving liposomal amphotericin B and caspofungin for suspected aspergillosis. Infection 2005; 33(5-6):397-400. Pubmed.

Wagner D, Maser J, Moric I, Boechat N, Vogt S, Gicquel B, Lai B, Reyrat JM, Bermudez L.. Changes of the phagosomal elemental concentrations by Mycobacterium tuberculosis Mramp. Microbiology 2005; 151(Pt 1):323-332. Pubmed

Wagner D, Maser J, Lai B, Barry CE 3rd, Höner Zu Bentrup K, Russell DG, Bermudez LE. Elemental analysis of Mycobacterium avium-, Mycobacterium tuberculosis-, and Mycobacterium smegmatis-containing phagosomes indicates pathogen-induced microenvironments within the host cell's endosomal system. J Immunol 2005; 174(3):1491-1500. Pubmed.

Kern WV, Wagner D, Hirsch HH. [Infections after organ transplantation]. Internist (Berl) 2005; 46(6):630-642. Pubmed.

Wagner D, Young LS. Nontuberculous mycobacterial infections: a clinical review. Infection 2004; 32(5):257-270. Pubmed.

Wagner D, de WK, Huzly D, Hufert F, Weidmann M, Breisinger S, Eppinger S, Kern WV, Bauer TM. Nosocomial acquisition of dengue. Emerg Infect Dis 2004; 10(10):1872-1873. Pubmed.

McGarvey JA, Wagner D, Bermudez LE. Differential gene expression in mononuclear phagocytes infected with pathogenic and non-pathogenic mycobacteria. Clin Exp Immunol 2004; 136(3):490-500. Pubmed.

Wagner D, Sangari FJ, Kim S, Petrofsky M, Bermudez LE. Mycobacterium avium infection of macrophages results in progressive suppression of interleukin-12 production in vitro and in vivo. J Leukoc Biol 2002; 71(1):80-88. Pubmed

Broxmeyer L, Sosnowska D, Miltner E, Chacón O, Wagner D, McGarvey J, Barletta RG, Bermudez LE. Killing of Mycobacterium avium and Mycobacterium tuberculosis by a mycobacteriophage delivered by a nonvirulent mycobacterium: a model for phage therapy of intracellular bacterial pathogens. J Infect Dis 2002; 186(8):1155-1160. Pubmed.

Limia A, Sangari FJ, Wagner D, Bermudez LE. Characterization and expression of secA in Mycobacterium avium. FEMS Microbiol Lett 2001; 197(2):151-157. Pubmed.

Bermudez LE, Wagner D, Sosnowska D. Mechanisms of Mycobacterium avium pathogenesis. Arch Immunol Ther Exp (Warsz ) 2000; 48(6):521-527. Pubmed.